Open AccessBiomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial
Author(s) -
JungYun Lee,
ByoungGie Kim,
Jae Weon Kim,
Jung Bok Lee,
Eunhyang Park,
JeGun Joung,
Sunghoon Kim,
Chel Hun Choi,
Hee Seung Kim
Publication year - 2022
Publication title -
journal of gynecologic oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.358
H-Index - 37
eISSN - 2005-0399
pISSN - 2005-0380
DOI - 10.3802/jgo.2022.33.e45
Subject(s) - medicine , olaparib , topotecan , durvalumab , oncology , paclitaxel , ovarian cancer , pharmacology , cancer , chemotherapy , immunotherapy , nivolumab , biochemistry , chemistry , polymerase , poly adp ribose polymerase , gene